Mozambique

2 Vaccines Approved for Use in Mozambique

Non Replicating Viral Vector

Oxford/AstraZeneca

Vaxzevria

Approved in 140 countries
64 trials in 31 countries
Approval Source: allafrica.com
Inactivated

Sinopharm (Beijing)

Covilo

Approved in 91 countries
30 trials in 12 countries
Approval Source: herald.co.zw

2 in Clinical Trials in Mozambique

Non Replicating Viral Vector

Oxford/AstraZeneca

Vaxzevria

Approved in 140 countries
64 trials in 31 countries
Inactivated

Sinopharm (Beijing)

Covilo

Approved in 91 countries
30 trials in 12 countries